Please login to the form below
tuberculosis
This page shows the latest tuberculosis news and features for those working in and with pharma, biotech and healthcare.
UK scientists begin testing BCG vaccine for severe COVID-19 protection
The BCG vaccine, originally developed in 1921, is traditionally used to protect against tuberculosis although it is no longer routinely administered in the UK.
Latest news
-
Researchers discover new antibiotic using AI
That included showing efficacy against tuberculosis and strains of bacteria which are considered untreatable or resistant to currently approved antibiotics.
-
GSK licenses its tuberculosis vaccine to Gates MRI
Vaccine has demonstrated around 50% efficacy in preventing disease. GlaxoSmithKline is out in front among efforts to develop a new vaccine against tuberculosis, but has decided it won’t take the
-
Antibiotic biotech Melinta files for bankruptcy
Certain infections, such as pneumonia, tuberculosis, blood poisoning, gonorrhoea and others are becoming resistant to standard antibiotics, making them increasingly hard-to-treat.
-
The NHS is facing shortages of lifesaving treatments, says internal document
In addition to identifying these new drug shortages, the document also revealed ongoing issues with 69 different types and doses of medication including antibiotics for tuberculosis, diamorphine, various cancer drugs, heart
-
GSK's pivotal TB vaccine could prevent millions of deaths
GlaxoSmithKline has announced that its IAVI-partnered experimental tuberculosis (TB) vaccine candidate significantly reduced the occurrence of pulmonary tuberculosis disease. . ... These final results show that M72/AS01E could be an important tool in
More from news
Approximately 19 fully matching, plus 112 partially matching documents found.
Latest Intelligence
-
How will COVID-19 affect uptake of vaccinations against other diseases?
BCG, widely used for childhood immunisation against tuberculosis, has been particularly affected due to experimental use as a treatment for COVID-19.
-
Risks, reforms and rewards: the evolving Russian healthcare market
Tuberculosis and Malaria.
-
COVID-19 hits supply chains
An FDA study found that at least three WHOdesignated ‘essential medicines’ are made from APIs sourced only in China: capreomycin and streptomycin, both used to treat tuberculosis; and sulfadiazine, used to
-
Biotech profile: Tom Evans, CEO, Vaccitech.
In September 2010 he joined Aeras, a non-profit Product Development Partnership with a mission to develop global tuberculosis vaccines, as the Chief Scientific Officer, and became CEO in February 2013.
-
Combining therapies and combining research
Combination therapy. Antibiotic Combination Therapy was developed in 1952 for the treatment of tuberculosis. ... Combination therapy is the norm in the treatment of many cancers and viral infections such as HIV and even some bacterial diseases such as
More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.
Latest appointments
-
Former Merck & Co exec to lead Seres
In total Dr Pomerantz has been involved with the development of eight approved drugs for infectious diseases, covering HIV, hepatitis C and tuberculosis.
-
GlycoVaxyn appoints Gerd Zettlmeissl as chairman
He currently serves on the boards of several biotechnology companies including Aeras, an organisation dedicated to the development of tuberculosis vaccines.
-
Former PEPFAR head Mark Dybul to lead the Global Fund
Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark Dybul as executive director.
More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Antibiotic resistance: The silent pandemic
The impact. An increasing number of common infections such as pneumonia, tuberculosis, gonorrhoea and salmonellosis are becoming harder to treat as antibiotics become less effective. ... The global statistics. 123 countries report extensive multi-drug
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
2. Characterised by very low levels of CD4+ T cells, and the presence of AIDS-related pathologies (such as tuberculosis and Kaposi’s sarcoma), the diagnosis of AIDS marks just how
-
Could ketamine be the next big thing in depression?
Doctors noticed that tuberculosis patients treated with isoniazid showed signs of improved mood.
-
Exploring MINT: Part 4 - Turkey
due to migration to the urban centres of the west. In Eastern Turkey, outbreaks of communicable diseases such as tuberculosis are still occurring. Pharma investment therefore remains focused on the western
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Account Director
-
Competitive
- Nucleus Global announces a trio of promotions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Pfizer introduces new logo in a ‘shift from commerce to science’
- PHE study finds people who have had COVID-19 can still transmit the virus
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New study identifies drugs that are safe to use in COVID-19 treatment
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
